HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoto Nakamura Selected Research

gluconolactonase

1/2015Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes.
3/2012Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoto Nakamura Research Topics

Disease

67Type 2 Diabetes Mellitus (MODY)
10/2018 - 01/2002
19Cardiovascular Diseases (Cardiovascular Disease)
07/2015 - 06/2003
16Insulin Resistance
01/2016 - 01/2004
15Atherosclerosis
05/2015 - 01/2006
14Diabetic Nephropathies (Diabetic Nephropathy)
11/2019 - 09/2002
12Hypertension (High Blood Pressure)
01/2021 - 12/2006
12Diabetes Mellitus
12/2019 - 08/2002
11Hyperglycemia
05/2016 - 01/2004
11Albuminuria
01/2016 - 09/2007
7Neoplasms (Cancer)
01/2022 - 04/2002
7Endometriosis
12/2007 - 01/2002
6Dyslipidemias (Dyslipidemia)
01/2021 - 03/2012
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 03/2010
5Genetic Predisposition to Disease (Genetic Predisposition)
12/2007 - 01/2002
4Infections
03/2020 - 09/2006
4Autoimmune Diseases (Autoimmune Disease)
10/2019 - 09/2006
4Diabetes Complications
06/2017 - 07/2008
4Fatty Liver
01/2016 - 01/2011
4Non-alcoholic Fatty Liver Disease
04/2013 - 04/2010
4Scrapie
03/2007 - 08/2003
3Periodontitis
09/2017 - 10/2010
3Obesity
09/2015 - 01/2004
3Inflammation (Inflammations)
01/2014 - 03/2010
3Glucose Intolerance
03/2012 - 03/2008
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2011 - 08/2003
3Carotid Artery Diseases
02/2008 - 06/2003
3Body Weight (Weight, Body)
10/2005 - 01/2004
3Neuroblastoma
09/2005 - 08/2003
2Thrombosis (Thrombus)
01/2019 - 11/2003
2Peripheral Arterial Disease
06/2017 - 07/2013
2Abdominal Obesity
01/2016 - 11/2015
2Hypertriglyceridemia
01/2016 - 11/2015
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2015 - 07/2012
2Atrophic Gastritis
07/2012 - 04/2012
2Overnutrition
04/2012 - 03/2010
2Hyperinsulinism (Hyperinsulinemia)
03/2011 - 10/2010
2Hyperlipidemias (Hyperlipidemia)
06/2010 - 02/2007
2Communicable Diseases (Infectious Diseases)
06/2010 - 12/2002

Drug/Important Bio-Agent (IBA)

25AlbuminsIBA
11/2019 - 01/2004
18Hemoglobins (Hemoglobin)IBA
01/2021 - 03/2008
15LipidsIBA
03/2013 - 06/2003
13Glucose (Dextrose)FDA LinkGeneric
10/2016 - 01/2004
12CreatinineIBA
12/2019 - 08/2012
11Testosterone (Sustanon)FDA Link
08/2013 - 06/2003
8Indicators and Reagents (Reagents)IBA
11/2020 - 09/2006
8Uric Acid (Urate)IBA
10/2017 - 05/2008
7CytokinesIBA
06/2016 - 08/2004
7Triglycerides (Triacylglycerol)IBA
01/2016 - 01/2011
7Insulin (Novolin)FDA Link
07/2013 - 07/2005
7AntibodiesIBA
06/2009 - 08/2003
5CholesterolIBA
12/2019 - 02/2008
5AndrogensIBA
08/2013 - 02/2007
5C-Reactive ProteinIBA
05/2013 - 12/2008
5Blood Glucose (Blood Sugar)IBA
03/2013 - 08/2003
5Dehydroepiandrosterone (DHEA)IBA
07/2008 - 12/2004
5Prion ProteinsIBA
10/2007 - 06/2002
5Dehydroepiandrosterone SulfateIBA
09/2007 - 12/2004
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2017 - 03/2008
4HDL CholesterolIBA
01/2016 - 04/2015
4Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2006
4BilirubinIBA
06/2014 - 11/2008
4Biomarkers (Surrogate Marker)IBA
03/2013 - 12/2006
4Lipoproteins (Lipoprotein)IBA
01/2013 - 04/2008
4Hemoglobin AIBA
12/2012 - 09/2007
4EnzymesIBA
09/2006 - 04/2003
3Antihypertensive Agents (Antihypertensives)IBA
11/2019 - 12/2012
3AntigensIBA
10/2019 - 11/2002
3Pharmaceutical PreparationsIBA
04/2016 - 01/2011
3AcidsIBA
07/2015 - 10/2007
3glimepiride (Amarel)FDA LinkGeneric
01/2014 - 10/2005
3oxidized low density lipoproteinIBA
01/2013 - 01/2010
3Pepsinogen A (Pepsinogen)IBA
01/2013 - 04/2012
3Fatty Acids (Saturated Fatty Acids)IBA
01/2013 - 11/2010
3nasIBA
01/2011 - 04/2010
3ResistinIBA
11/2007 - 01/2004
3Monoclonal AntibodiesIBA
10/2007 - 08/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2006 - 09/2003
2SteroidsIBA
08/2019 - 12/2002
2Metformin (Glucophage)FDA LinkGeneric
05/2016 - 01/2010
2Propolis (Bee Bread)IBA
05/2015 - 03/2013
2gluconolactonaseIBA
01/2015 - 03/2012
2Angiotensin Receptor AntagonistsIBA
06/2014 - 09/2007
2cyclopropapyrroloindoleIBA
05/2013 - 10/2010
2Brain Natriuretic Peptide (Natrecor)FDA Link
03/2013 - 09/2003
2Messenger RNA (mRNA)IBA
01/2013 - 06/2002
2LDL CholesterolIBA
12/2012 - 01/2011
2SurvivinIBA
09/2012 - 07/2012
2sepantroniumIBA
09/2012 - 07/2012
2Hydroxyindoleacetic AcidIBA
01/2012 - 08/2009
2Serotonin (5 Hydroxytryptamine)IBA
01/2012 - 08/2009
2ErbB Receptors (EGF Receptor)IBA
01/2012 - 06/2009
2Ezetimibe (Zetia)FDA Link
01/2011 - 11/2010
2LDL Lipoproteins (beta Lipoproteins)IBA
04/2010 - 04/2008
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2010 - 10/2005
2AdiponectinIBA
01/2010 - 12/2006
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2009 - 02/2003

Therapy/Procedure

15Glycemic Control
01/2021 - 12/2004
7Therapeutics
09/2015 - 11/2003
2Renal Dialysis (Hemodialysis)
11/2020 - 09/2003
2Drug Therapy (Chemotherapy)
01/2018 - 07/2012